In the News

Lowering colorectal cancer screening age from 50 to 45 years appears cost-effective

Initiating screening at age 45 years would require an additional 10 million colonoscopies, which could potentially provide greater benefit if used instead to increase screening rates in older patients, authors of the modeling study said.

Efficacy, safety of second-line therapies analyzed for two types of IBS

A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.

Beta-blockers linked to better outcomes in some patients with cirrhosis

Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.

MKSAP quiz: Long-term management of GERD

This month's quiz asks readers to determine the next step in management for a 75-year-old woman with longstanding gastroesophageal reflux disease (GERD) and a new diagnosis of osteopenia.

Spotlight on mental health and gastrointestinal symptoms

One recent study found a link between depression and diarrhea and constipation, while another found that cognitive behavioral therapy may be an effective treatment for patients with refractory irritable bowel syndrome.

Patients had high adherence to HCV treatment delivered in opioid agonist therapy programs

The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.

Hints for preventive care in inflammatory bowel disease

Age-appropriate, up-to-date vaccination is key.

Top 5 myths about celiac disease

Common misconceptions about the disease can lead to missed or delayed diagnosis.

New data show even higher rates of duodenoscope contamination

The FDA is exploring additional steps to reduce contamination rates, which were higher in postmarket surveillance studies than the agency initially anticipated.